Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review

Area of Science:

• Pharmacology
• Pain Management
• Cannabinoid Research

Background:

• Chronic pain affects many individuals and presents significant treatment challenges.
• Cannabinoids, specifically cannabidiol (CBD), are being explored for analgesic properties, potentially avoiding tolerance and dependence issues.
• While plant-derived CBD products are accessible for self-medication, synthetic CBD is under investigation for medical applications.

Purpose of the Study:

• To evaluate the potential of synthetic cannabidiol (CBD) as an analgesic for chronic pain.
• To address the unmet clinical need for effective and safe chronic pain management strategies.
• To explore the efficacy of synthetic CBD, particularly in long-term administration methods.

Main Methods:

• Review of existing clinical trials and research on synthetic CBD for pain indications.
• Analysis of studies investigating CBD's efficacy in chronic pain, neuropathic pain, and cancer pain.
• Consideration of multimodal CBD therapy, including combinations with other compounds like palmitoylethanolamide.

Main Results:

• Synthetic CBD is being studied in over 60 clinical trials for various pain conditions.
• Current studies are often small, with heterogeneous populations, leading to equivocal results.
• CBD generally exhibits mild and infrequent side effects, with no reported tolerance or dependence.

Conclusions:

• Synthetic CBD holds promise for chronic pain management, especially with long-lasting administration methods.
• Multimodal CBD therapy, potentially combined with palmitoylethanolamide, warrants further investigation.
• Increased patient education and comprehensive studies are essential to fully understand and utilize synthetic CBD for pain control.